Owens&Minor Investor Conference Presentation Deck

Proven Track Record of Successfully Integrating Acquisitions Byram and Halyard acquisitions have diversified the business and strengthened OMI's financial profile Target Description Strategic Rationale Impact 10 Acquired Aug 2017 Byram HEALTHCARE A leading distributor of medical supplies focused on chronic conditions sold directly to patients and home health agencies in the U.S. Diversified the Company's revenue streams across the continuum of care with a higher margin business Complemented transaction processing and developed OMI's expertise in managing third party reimbursement Operated in fragmented market with strong growth Patient Direct business has experienced significant growth since the acquisition of Byram in 2017, representing approximately a ~20% CAGR¹ since acquisition I I I I T Acquired April 2018 ✪ HALYARD D S&IP Business A leading global provider of medical supplies and solutions for the prevention of healthcare-associated infections Substantially augmented owned-brand portfolio to gain scale via targeted vertical integration Allowed company to cross-sell across existing relationships in acute and non-acute settings Expanded sourcing scale and capabilities Global products business² has experienced significant growth since the acquisition of Halyard in 2018 - net revenue has increased from $1,434 million in 2019 to $2,656 million in 2021, representing a 36% CAGR1,3 ¹ Beginning benchmark year represents the first full financial year post-acquisition; 2 Global Products was formerly its own segment and is now included within the Products & Healthcare Services segment as of Q1 2022, and includes other legacy priority products and OMI's kitting business:³ Excludes impact of inter-segment revenue Owens M&Minor

View entire presentation